Glenview Trust Co
- SEC CIK
- 0001691827
- Latest filing
- Aug 18, 2026
AZN holding history
AstraZeneca PLC in every 13F filed by Glenview Trust Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AZN overviewAll 13F holders of AZNFull Q2 2026 holdings
- Shares (Q2 2026)
- 4,346
- Value
- $824.1K
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 4,346 | $824.1K | <0.1% | +396+10.0% | Added | Holders |
| Q1 2026 | 3,950 | $779.0K | <0.1% | 00.0% | UnchangedConverted for a 1-for-2 split | Holders |
| Q4 2025 | 7,923 | $728.4K | <0.1% | +3,130+65.3% | Added | Holders |
| Q3 2025 | 4,793 | $367.7K | <0.1% | −314−6.1% | Reduced | Holders |
| Q2 2025 | 5,107 | $356.9K | <0.1% | +765+17.6% | Added | Holders |
| Q1 2025 | 4,342 | $319.1K | <0.1% | −71−1.6% | Reduced | Holders |
| Q4 2024 | 4,413 | $289.1K | <0.1% | −17−0.4% | Reduced | Holders |
| Q3 2024 | 4,430 | $345.1K | <0.1% | −1,222−21.6% | Reduced | Holders |
| Q2 2024 | 5,652 | $440.8K | <0.1% | +997+21.4% | Added | Holders |
| Q1 2024 | 4,655 | $315.4K | <0.1% | −122−2.6% | Reduced | Holders |
| Q4 2023 | 4,777 | $321.7K | <0.1% | +53+1.1% | Added | Holders |
| Q3 2023 | 4,724 | $319.9K | <0.1% | +174+3.8% | Added | Holders |
| Q2 2023 | 4,550 | $325.6K | <0.1% | +172+3.9% | Added | Holders |
| Q1 2023 | 4,378 | $303.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 4,378 | $296.8K | <0.1% | +220+5.3% | Added | Holders |
| Q3 2022 | 4,158 | $228.0K | <0.1% | +4,158 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −6,172−100.0% | Sold out | Holders |
| Q3 2021 | 6,172 | $371.0K | <0.1% | +6,172 | New | Holders |